This would be a good week to set aside extra time to read the newsletter. There is so much information that I almost thought about splitting it up into 2 weeks but our publisher, Steve Freed, wouldn’t let me. We begin by finishing up with Part 4 of our special …
Read More »Daily Archives: Feb 3, 2018
Improving Cardiovascular Outcomes with Better Cholesterol Control
Does adding Zetia to a multifaceted drug therapy regimen help improve health outcomes?
Read More »Gestational Diabetes Mellitus: Revised Diagnostic Criteria Can Help Improve Pregnancy Outcomes
A closer look into what’s new according to the WHO shows if more women are at risk for gestational diabetes than thought.
Read More »A New Method To Get Your Patients To Exercise
Letting your patients know how long they may survive and how to extend their survival time can get your patients to increase their physical activity or get them to start.
Read More »Is Weight Loss the Secret Behind Remission of Type 2 Diabetes?
T2D diagnosed within last 6 years may be able to achieve remission if substantial weight loss is achieved.
Read More »Are You Getting Enough “SPA” Time?
By Sheri R. Colberg: Exploring the Benefits of Spontaneous Physical Activity
You’ve probably heard about the recent reports revealing just how dangerous it is to be sedentary. Simply sitting for too long at one time is now a recognized health hazard that everyone should be aware of. But if you suffer from diabetes or prediabetes, a sedentary lifestyle is particularly dangerous. Getting regular exercise and movement is one of the most important things you can do to keep your blood glucose under control, maintain a healthy body weight, and reduce your risk of developing complications related to diabetes.
Recommending a Sulfonylurea
What percentage of time do you recommend a sulfonylurea because that is what the patient can afford? Follow the link to see how you compare to your colleagues.
Read More »Adding Basal Insulin Analogue Detemir
A 59-year-old patient who was diagnosed with type 2 diabetes five years ago presents to your clinic for an appointment. He has a history of hypertension and dyslipidemia, both currently well-controlled with medication. He has been taking metformin and a DPP-4 inhibitor. He tells you he is concerned about a sore on his foot that is taking a long time to heal. At today’s visit, his office A1C is 8.8%. After discussing his options, you decide to add basal insulin analogue detemir to his regimen. Compared to insulin NPH, what would you expect him to experience while taking detemir? A. Less weight gain B. More hypoglycemia C. More weight gain D. No weight gain or hypoglycemia difference Follow the link for the answer.
Read More »Ken Fujioka Current Interview
Ken Fujioka is director of the Nutrition and Metabolic Research Center and the Center for Weight Management in La Jolla California at the Scripps Clinic. His time is divided equally between clinical research and clinical practice. Research includes diets, medications, bariatric surgery, medical devices, web based weight loss programs, and outcomes in obesity treatment.
Read More »Ken Fujioka Transcript
In this Exclusive Interview transcript Dr. Ken Fujioka talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 Scientific Sessions in San Diego, CA, about his work in both clinical practice and clinical research on treating obesity and how weight loss affects type 2 diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.